Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the ...

Novartis, a leading global innovative medicines company and the official pharmaceutical partner of the NFL, today announced the launch of "Relax, it's a blood test," a new national prostate cancer ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...

Six-time Olympic gold medalist Sir Chris Hoy recently revealed he has terminal prostate cancer. Amid Hoy’s diagnosis, experts are urging men to keep an eye out for an easy-to-miss sign of prostate ...

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

Prostate cancer cases have been on the rise in recent years, increasing 3% annually since 2014 – and now former President Joe Biden is one of the more than 300,000 men to be diagnosed this year. Biden ...

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

Former President Joe Biden was diagnosed with an "aggressive form" of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president's prostate cancer is characterized ...